Ebastine

DRUG6 trials

Conditions

Hepato Cellular CarcinomaIBSIBS - Irritable Bowel SyndromeIrritable Bowel SyndromeIrritable Bowel Syndrome (IBS)Irritable Bowel Syndrome - DiarrhoeaUrticaria

Phase 2

Effect of Ebastine in Patients With Diarrhea Predominant Irritable Bowel Syndrome

RecruitingNCT07114055

Md. Hazrat AliIrritable Bowel Syndrome - Diarrhoea

Start: 2025-08-15End: 2026-07-31Target: 60Updated: 2025-08-20

Phase 3

Ebastine Versus Mebeverine in IBS Patients

Active, not recruitingNCT05815602

Guy BoeckxstaensIBS, IBS - Irritable Bowel Syndrome

Start: 2023-03-30End: 2028-01-01Target: 200Updated: 2026-09-11

Phase 4

Irritable Bowel Syndrome (IBS) Treatment With H1-receptor Antagonists

CompletedNCT01144832

KU LeuvenIrritable Bowel Syndrome

Start: 2009-10-31End: 2012-05-31Updated: 2016-01-28

Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter Trial

CompletedNCT01908465

KU LeuvenIrritable Bowel Syndrome (IBS)

Start: 2013-11-30End: 2022-11-02Updated: 2023-02-08

Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria

CompletedNCT01940393

Grupo de Alergología Clínica y ExperimentalUrticaria

Start: 2013-08-31End: 2014-01-31Updated: 2014-02-19

Ebastine for Adjuvant Treatment of Tumor Budding-Positive Liver Cancer After Surgery

Not yet recruitingNCT07734766

Second Affiliated Hospital of Xi'an Jiaotong UniversityHepato Cellular Carcinoma

Start: 2026-10-01End: 2030-03-01Target: 45Updated: 2026-07-29

Related Papers

Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial

Gut2024-01-0826 citations

Evaluation of a Guidelines-Based Approach to the Treatment of Chronic Spontaneous Urticaria.

2017-07-1228 citations

Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.

2016-01-02264 citations